Recent studies demonstrated that inhibiting mevalonate pathway by statins might destabilize and thereby degrade mutant p53, leading to tumour cell death.68, 69, 70, 71 We noted in this study that mutant p53‐harbouring MDA‐MB‐468 and MDA‐MB‐231 cells are sensitive to lovastatin. The gene discussed is TP53; the disease is neoplasm.